Agile Therapeutics, Inc. (AGRX)
How AGRX actually reacts to news — the realized, point-in-time move the market made, measured across 90 labeled events over the last three years with zero look-ahead.
AGRX’s median reaction, across the day.
Half of all Agile Therapeutics, Inc. news events land between -1.59% and +1.47% at 30 minutes.
Reaction stats as of 2026-08-13. Reaction = percent move vs. the price at the news timestamp.
Email me when AGRX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to AGRX’s baseline. Nothing else.
Get “How AGRX reacts to news” as a PDF.
A free one-page summary: AGRX’s median reaction to news and the full breakdown by event type — the numbers on this page, in one page.
Recent AGRX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L. | Press release | GlobeNewswire | — | — | |
| Form 8-K AGILE THERAPEUTICS INC For: Aug 22 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form POS AM AGILE THERAPEUTICS INC | SEC filing · Form POS | SEC EDGAR | — | — | |
| Form S-8 POS AGILE THERAPEUTICS INC | SEC filing · Form S-8 | SEC EDGAR | — | — | |
| Form 10-Q AGILE THERAPEUTICS INC For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.69% | |
| Form DEFM14A AGILE THERAPEUTICS INC | SEC filing · Form DEFM14A | SEC EDGAR | +0.70% | +0.70% | |
| Form 8-K/A AGILE THERAPEUTICS INC For: Jun 25 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.70% | |
| Form DEFA14A AGILE THERAPEUTICS INC | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | +0.70% | |
| Form 8-K/A AGILE THERAPEUTICS INC For: May 15 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.70% | |
| Form PREM14A AGILE THERAPEUTICS INC For: Jul 12 | SEC filing · Form PREM14A | SEC EDGAR | +1.42% | +0.71% | |
| Form RW AGILE THERAPEUTICS INC | SEC filing · Form RW | SEC EDGAR | +0.00% | +1.00% | |
| Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L. | Press release | GlobeNewswire | +10.85% | +11.63% | |
| AGRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Agile Therapeutics, Inc. Is Fair to Shareholders | Press release | Business Wire | +0.50% | +2.64% | |
| Form 8-K AGILE THERAPEUTICS INC For: Jun 25 | SEC filing · Form 8-K | SEC EDGAR | +10.85% | +11.63% | |
| Form DEFA14A AGILE THERAPEUTICS INC | SEC filing · Form DEFA14A | SEC EDGAR | +10.85% | +11.63% | |
| Form S-1 AGILE THERAPEUTICS INC | SEC filing · Form S-1 | SEC EDGAR | -2.25% | -5.05% | |
| Form 8-K AGILE THERAPEUTICS INC For: May 15 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +8.56% | |
| Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | GlobeNewswire | +0.30% | +5.46% | |
| Form 10-Q AGILE THERAPEUTICS INC For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.30% | +5.46% | |
| Form 8-K AGILE THERAPEUTICS INC For: May 15 | SEC filing · Form 8-K | SEC EDGAR | +0.30% | +5.46% | |
| Form 10-K/A AGILE THERAPEUTICS INC For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +3.97% | |
| Form 8-K AGILE THERAPEUTICS INC For: Apr 09 | SEC filing · Form 8-K | SEC EDGAR | +7.26% | -0.86% | |
| Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update | Press release | GlobeNewswire | +17.12% | +2.10% | |
| Form 10-K AGILE THERAPEUTICS INC For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.30% | -18.55% | |
| Form 8-K AGILE THERAPEUTICS INC For: Mar 28 | SEC filing · Form 8-K | SEC EDGAR | +17.12% | +2.10% | |
| Agile Therapeutics Announces Delisting from Nasdaq | Press release | GlobeNewswire | -0.83% | +39.46% | |
| Form 8-K AGILE THERAPEUTICS INC For: Mar 22 | SEC filing · Form 8-K | SEC EDGAR | -0.83% | +39.46% | |
| Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024 | Press release | GlobeNewswire | -0.65% | -3.28% | |
| Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024 | Press release | GlobeNewswire | +1.33% | +9.66% | |
| Form 8-K AGILE THERAPEUTICS INC For: Mar 13 | SEC filing · Form 8-K | SEC EDGAR | -4.58% | -7.97% | |
| Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution | Press release | GlobeNewswire | -5.23% | -14.94% | |
| Form 8-K AGILE THERAPEUTICS INC For: Feb 22 | SEC filing · Form 8-K | SEC EDGAR | -1.66% | -1.43% | |
| Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds | Press release | GlobeNewswire | -7.25% | -27.68% | |
| Thinking about buying stock in Agile Therapeutics, Nano-X Imaging, Eastside Distilling, Root Inc, or GigaCloud Technology? | Press release | PR Newswire | -3.33% | -25.54% | |
| Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update | Press release | GlobeNewswire | -0.80% | -4.00% | |
| Form 8-K AGILE THERAPEUTICS INC For: Feb 09 | SEC filing · Form 8-K | SEC EDGAR | -0.80% | -4.00% | |
| Form S-1/A AGILE THERAPEUTICS INC | SEC filing · Form S-1 | SEC EDGAR | -2.34% | -6.25% | |
| Form S-1/A AGILE THERAPEUTICS INC | SEC filing · Form S-1 | SEC EDGAR | +0.00% | -2.72% | |
| Form S-1/A AGILE THERAPEUTICS INC | SEC filing · Form S-1 | SEC EDGAR | +0.00% | -2.72% | |
| The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost | Press release | GlobeNewswire | -1.35% | -2.03% | |
| Form S-1/A AGILE THERAPEUTICS INC | SEC filing · Form S-1 | SEC EDGAR | +0.98% | -0.98% | |
| Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage Requirement | Press release | GlobeNewswire | +0.45% | -6.42% | |
| Form S-1 AGILE THERAPEUTICS INC | SEC filing · Form S-1 | SEC EDGAR | +0.45% | -6.42% | |
| Form 8-K AGILE THERAPEUTICS INC For: Dec 05 | SEC filing · Form 8-K | SEC EDGAR | -7.34% | -11.20% | |
| Form 8-K AGILE THERAPEUTICS INC For: Dec 03 | SEC filing · Form 8-K | SEC EDGAR | +0.92% | +13.82% | |
| Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024 | Press release | Accesswire | — | -3.29% | |
| Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Press release | GlobeNewswire | +0.50% | +2.50% | |
| Form 10-Q AGILE THERAPEUTICS INC For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.89% | -5.66% | |
| Form 8-K AGILE THERAPEUTICS INC For: Nov 09 | SEC filing · Form 8-K | SEC EDGAR | +0.50% | +2.50% | |
| Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023 | Press release | GlobeNewswire | +0.54% | -1.63% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the AGRX section they belong to.
More of the dataset.
AGRX earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Agile Therapeutics, Inc.'s median reaction calculated?
Every labeled AGRX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 90 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 40% of AGRX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-08-13.
Does AGRX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.